FI932959A - Kinoxalin derivat, deras framstaellning och anvaendning i laekemedel - Google Patents

Kinoxalin derivat, deras framstaellning och anvaendning i laekemedel Download PDF

Info

Publication number
FI932959A
FI932959A FI932959A FI932959A FI932959A FI 932959 A FI932959 A FI 932959A FI 932959 A FI932959 A FI 932959A FI 932959 A FI932959 A FI 932959A FI 932959 A FI932959 A FI 932959A
Authority
FI
Finland
Prior art keywords
laekemedel
deras framstaellning
framstaellning och
och anvaendning
kinoxalin
Prior art date
Application number
FI932959A
Other languages
English (en)
Other versions
FI932959A0 (fi
Inventor
Andreas Huth
Ralph Schmiechen
Ilse Beetz
Ingrid Schumann
Lechoslaw Turski
Peter Andreas Loeschmann
David Norman Stephens
Dieter Seidelmann
Martin Krueger
Dieter Rahtz
Peter Hoelscher
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4135871A external-priority patent/DE4135871A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI932959A publication Critical patent/FI932959A/fi
Publication of FI932959A0 publication Critical patent/FI932959A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI932959A 1991-10-26 1993-06-24 Kinoxalin derivat, deras framstaellning och anvaendning i laekemedel FI932959A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4135871A DE4135871A1 (de) 1991-10-26 1991-10-26 Chinoxalinderivate, deren herstellung und verwendung in arzneimitteln
DE4224200 1992-07-17
PCT/DE1992/000895 WO1993008173A1 (de) 1991-10-26 1992-10-25 Chinoxalin-derivate, mit affinität an die quisqualat-rezeptoren

Publications (2)

Publication Number Publication Date
FI932959A true FI932959A (fi) 1993-06-24
FI932959A0 FI932959A0 (fi) 1993-06-24

Family

ID=25908683

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932959A FI932959A0 (fi) 1991-10-26 1993-06-24 Kinoxalin derivat, deras framstaellning och anvaendning i laekemedel

Country Status (17)

Country Link
EP (1) EP0565683A1 (fi)
JP (1) JP3258008B2 (fi)
KR (1) KR100262371B1 (fi)
CN (1) CN1038840C (fi)
AU (1) AU664212B2 (fi)
CA (1) CA2099270A1 (fi)
CZ (1) CZ286351B6 (fi)
FI (1) FI932959A0 (fi)
HU (1) HUT64756A (fi)
IL (1) IL103538A (fi)
NO (1) NO304693B1 (fi)
NZ (1) NZ244896A (fi)
PL (1) PL171125B1 (fi)
PT (1) PT101004B (fi)
RU (1) RU2117663C1 (fi)
SK (1) SK281518B6 (fi)
WO (1) WO1993008173A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162491D0 (da) * 1991-09-20 1991-09-20 Novo Nordisk As Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
PT647137E (pt) * 1992-06-22 2008-11-24 Univ California Antagonistas dos receptores da glicina e a sua utilização
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE4314592A1 (de) * 1993-04-28 1994-11-03 Schering Ag Benzo(f)chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE4428152A1 (de) * 1994-06-22 1996-01-04 Basf Ag Neue Amido-chinoxalindione, ihrer Herstellung und Verwendung
GB9419318D0 (en) * 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
WO1996010023A1 (fr) * 1994-09-27 1996-04-04 Yamanouchi Pharmaceutical Co., Ltd. Derive de 1,2,3,4-tetrahydroquinoxalindione
DE4439493A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US6110911A (en) * 1995-06-07 2000-08-29 Warner-Lambert Company Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
DE19521058A1 (de) * 1995-06-09 1996-12-12 Basf Ag Verfahren zur Herstellung von Aromaten enthaltenden Polyetherpolyolen
DE19545251A1 (de) * 1995-11-24 1997-05-28 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
TW448171B (en) * 1996-06-06 2001-08-01 Yamanouchi Pharma Co Ltd Imidazole-substituted quinoxalinedione derivatives
DE19624808A1 (de) 1996-06-21 1998-01-02 Basf Ag Pyrrolylchinoxalindione, ihre Herstellung und Verwendung
DE19728326A1 (de) * 1997-06-27 1999-01-07 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US6015800A (en) * 1997-09-03 2000-01-18 Warner-Lambert Company Substituted quinoxaline-2-ones as glutamate receptor antagonists
EP0900567A3 (en) * 1997-09-05 2001-05-02 Pfizer Products Inc. Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
IL125950A0 (en) * 1997-09-05 1999-04-11 Pfizer Prod Inc Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
FR2769309B1 (fr) 1997-10-08 2001-06-15 Oreal Composition de teinture d'oxydation des fibres keratiniques comprenant un derive d'aminoacide en tant que base d'oxydation et nouveaux derives d'aminoacides
GB0311406D0 (en) * 2003-05-17 2003-06-25 Queen Mary & Westfield College Substituted phosphonate fluorescent sensors,and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0118982A1 (en) * 1983-02-01 1984-09-19 Sumitomo Chemical Company, Limited Organic phosphorous quinoxalinone and their production and use
NO179551C (no) * 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK69790D0 (da) * 1990-03-16 1990-03-16 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling af anvendelse

Also Published As

Publication number Publication date
SK72793A3 (en) 1993-10-06
NZ244896A (en) 1995-07-26
AU2889492A (en) 1993-05-21
CZ138793A3 (en) 1994-01-19
JP3258008B2 (ja) 2002-02-18
KR100262371B1 (ko) 2000-08-01
RU2117663C1 (ru) 1998-08-20
IL103538A (en) 2001-07-24
NO932344D0 (no) 1993-06-25
CN1038840C (zh) 1998-06-24
EP0565683A1 (de) 1993-10-20
JPH06503583A (ja) 1994-04-21
CA2099270A1 (en) 1993-04-27
PT101004B (pt) 1999-10-29
AU664212B2 (en) 1995-11-09
CZ286351B6 (cs) 2000-03-15
SK281518B6 (sk) 2001-04-09
HUT64756A (en) 1994-02-28
IL103538A0 (en) 1993-03-15
FI932959A0 (fi) 1993-06-24
NO932344L (no) 1993-06-25
HU9301877D0 (en) 1993-09-28
CN1072929A (zh) 1993-06-09
WO1993008173A1 (de) 1993-04-29
KR930703271A (ko) 1993-11-29
PL171125B1 (pl) 1997-03-28
PT101004A (pt) 1994-01-31
PL299929A1 (en) 1994-04-05
NO304693B1 (no) 1999-02-01

Similar Documents

Publication Publication Date Title
MX9205145A (es) Nuevos derivados heterociclicos.
NL300250I2 (nl) Chinuclidinederivaten.
NO922182L (no) Krystallinske oksatiolan-derivater
FI921943A (fi) Poroest bikaksmaterial, foerfarande foer framstaellning av det och anvaendning av det
FI923947A (fi) Foerfarande foer pulsbreddsmodulation foer oekad linearitet, minskad kommutationsfoerlust och oekad utspaenning i en vaexelriktare/omriktare
FI932959A (fi) Kinoxalin derivat, deras framstaellning och anvaendning i laekemedel
DE69110254D1 (de) Hydroxychinolonderivate.
FI925763A0 (fi) Fungicida 2-imidazolin-5-on- och 2-imidazolin-5-tionderivat
FI922721A (fi) Ammunitionskomponent med laog skadeegenskaper, med en tvaokomponentig explosionsladdning och foerfarande foer uppnaoende av en fragmentationseffekt
TR26336A (tr) SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI
FI891122A0 (fi) N-cyklopropylaniliner och deras anvaendning i foerfarandet foer framstaellning av 1-cyklopropylkinolonkarboxylsyror och deras derivat.
FI922390A (fi) Initiatorsuspensioner, deras framstaellning och anvaendning
FI922491A (fi) Foerbaettrad, fosfat och enzymer innehaollande, pulverformig diskmedelskomposition foer automatiska diskmaskiner
FI922979A (fi) 2-piperidin-1-yl)etanolderivat, deras framstaellning och terapeutiska anvaendning
FI922377A (fi) Glasblandning, daerav framstaellda glasfibrer och deras framstaellningsfoerfarande
FI922492A (fi) Fosfat och enzymer innehaollande, pulverformig diskmedelskomposition foer automatiska diskmaskiner
FI925469A (fi) Tiazolylsubstituerade kinolylymetoxifenylaettiksyraderivat
FI922389A0 (fi) Anordning foer framstaellning av en pressmantel avsedd foer bruk i pappersindustrin och pressmantel framstaelld daermed.
FI922876A (fi) Heterocykliska foereningar med reninhaemmande egenskaper, foerfarande foerframstaellning av dessa och anvaendning av dessa
DE59106761D1 (de) N-Acylpyrrolidin-Derivate.
FI925974A0 (fi) Humant rotavirus-hcr3, nyorganiserade stammar av detta och vaccinkompositioner innehaollande dessa
FI922980A (fi) 2-piperidinylpyrimidin-4-karboxamidderivat, framstaellning av dessa ochterapeutisk anvaendning av dessa
FI925639A0 (fi) Isoxazolylimidazolderivat, foerfarande foer deras framstaellning och deras anvaendning i laekemedel
FI923998A (fi) Derivat av maensklig bfgf, deras analoger och foerfarande foer deras framstaellning
KR930702353A (ko) 2- 카르바페넴 유도체